About this trial
To determine if prophylactic administration of amiodarone for 72 hours in critically ill patients admitted after an OHCA with shockable rhythm, with a confirmed or a presumed cardiac cause, decreases the incidence of a composite endpoint of 30-day (starting from inclusion) all-cause mortality and/or severe in-hospital ventricular arrhythmia recurrence (ventricular fibrillation and/or ventricular tachycardia requiring intervention including re-arrest)
Eligibility criteria
Qualifiers
Patient aged ≥ 18 years
Admitted in intensive care unit
Out-of-hospital cardiac arrest with initial shockable rhythm
Presumed cardiac or unknown cause
Disqualifiers
Cardiac arrest secondary to an extra-cardiac cause (suspected or confirmed)
Indication for amiodarone decided by the physician at ICU admission
No central venous catheter available for continuous infusion of amidoarone
Thyroid disease under treatment
Trial design
Treatments tested in this trial
- Amiodarone